A phase IB clinical trial of the sequence dependent combination of paclitaxel (P) and cisplatin (C) with the cyclin dependent kinase (CDK) inhibitor flavopiridol in patients with advanced solid tumors Meeting Abstract
| Authors: | Shah, M. A.; Kaubisch, A.; O'reilly, E.; Sharma, S.; Endres, S.; Welch, M.; Tong, W.; Spriggs, D.; Schwartz, G. K. |
| Abstract Title: | A phase IB clinical trial of the sequence dependent combination of paclitaxel (P) and cisplatin (C) with the cyclin dependent kinase (CDK) inhibitor flavopiridol in patients with advanced solid tumors |
| Meeting Title: | 92nd Annual Meeting of the American Association for Cancer Research (AACR) |
| Keywords: | drug regimen; meeting abstract |
| Journal Title: | Proceedings of the American Association for Cancer Research Annual Meeting |
| Volume: | 42 |
| Meeting Dates: | 2001 Mar 24-28 |
| Meeting Location: | New Orleans, LA |
| ISSN: | 0197-016X |
| Publisher: | American Association for Cancer Research |
| Date Published: | 2001-03-01 |
| Start Page: | 542 |
| End Page: | 543 |
| Language: | English |
| ACCESSION: | BCI:BCI200100468842 |
| PROVIDER: | biosis |
| Notes: | Meeting Abstract: 2917 -- Source: Biosis |
